Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1055-1063

  Griesinger, George ^a   Venetis, Christos A ^b   Marx, Tanja ^a   Diedrich, Klaus ^a   Tarlatzis, Basil C ^b   Kolibianakis, Efstratios M ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

antide; cetrorelix; ganirelix; GnRH antagonists; oral contraceptive pill

Indexed keywords

GANIRELIX; GONADORELIN ANTAGONIST; GONADOTROPIN DERIVATIVE; ITURELIX; ORAL CONTRACEPTIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; META ANALYSIS; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

CONTRACEPTIVES, ORAL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 52949126768     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.07.1354     Document Type: Article

References (16)

1. Kolibianakis E.M., Collins J., Tarlatzis B., Devroey P., Diedrich K., and Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH-analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 12 (2006) 651-671
2. Kolibianakis E.M., Tarlatzis B., and Devroey P. GnRH antagonists in IVF. Reprod Biomed Online 10 (2005) 705-712
3. Diedrich K., Diedrich C., Santos E., Zoll C., Al-Hasani S., Reissmann T., et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9 (1994) 788-791
4. Olivennes F., Alvarez S., Bouchard P., Fanchin R., Salat-Baroux J., and Frydman R. The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum Reprod 13 (1998) 2411-2414
5. Meldrum D., Scott R., Levy M.J., Alper M., and Noyes N. A pilot study to assess oral contraceptive (OC) pre-treatment in women undergoing controlled ovarian hyperstimulation (COH) in ganirelix acetate cycles. Fertil Steril 78 Suppl 1 (2002) S176
6. Fischl F., Huber J.C., and Obruca A. Zeitliche Optimierung der kontrollierten Hyperstimulation (KOH) in Kombination mit GnrH-Antagonisten und Ovulationshemmer in einem IVF-Programm. J Fertil Reprod 11 (2001) 50-51
7. Barmat L.I., Chantilis S.J., Hurst B.S., and Dickey R.P. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 83 (2005) 321-330
8. Bax L, Yu LM, Ikeda N, Tsuruta N, Moons KGM. MIX: comprehensive free software for meta-analysis of causal research data, Version 1,54. 2006. Available from Leon Bax, Department of Medical Informatics, Graduate School of Medical Sciences, Kitasato University, Kitasato 1-15-1, Sagamihara city, Kanagawa, 228-8555 Japan.
9. Higgins J.P.T., Thompson S.G., Deeks J.J., and Altman D.G. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
10. Galera V., Verdu V., Villafanez E., Garijo J., Rayward J., and Bajo J.M. Comparison of plasmatic steroid levels with and without previous oral contraceptive administration in GnRH-antagonist IVF cycles. Hum Reprod 82 Suppl 2 (2004) S32
11. Kim C.H., Lee H.A., Lee J.W., Lee Y.J., Nah H.Y., Hong S.H., et al. The efficacy of oral contraceptive pretreatment in controlled ovarian hyperstimulation using a GnRH-antagonist protocol in low responders. Hum Reprod 20 (2005) i105
12. Kolibianakis E.M., Papanikolaou E.G., Camus M., Tournaye H., Van Steirteghem A.C., and Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 21 (2006) 352-357
13. Huirne J.A., van Loenen A.C., Donnez J., Pirard C., Homburg R., Schats R., et al. Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study. Reprod Biomed Online 13 (2006) 235-245
14. Rombauts L., Healy D., and Norman R.J. Comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profi les in GnRH antagonist-treated patients. Hum Reprod 21 (2006) 95-103
15. Cédrin-Durnerin I, Bständig B, Parneix I, Bied-Damon V, Avril C, Decanter C, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod [Advance access August 26, 2006, doi:10.1093/humrep/del340].
16. Griesinger G., Felberbaum R., and Diedrich K. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod 20 (2005) 2373-2375